Recent Prospectives of Anticancer Histone Deacetylase Inhibitors

Recent review on selective histone deacetylase inhibitors in cancer therapy

HDAC as a cancer target: Various scaffolds based on HDAC inhibitors and an overview of their advances

Advances in non-Hydroxamate based Histone Deacetylase Inhibitors as Anticancer Agents

Histone Deacetylase Inhibitors in Cancer

RECENT ADVANCES IN DRUGS TARGETING PROTEIN KINASES FOR CANCER THERAPY.

Insights into Novel Drugs Targeting Bcl-2 protein as Potential Anti-cancer Agents

Novel Mannich Bases Derived from 2-Substituted Benzimidazole and (Thio)Hydantoin Moieties as Potent Histone Deacetylase 6 (HDAC6) Inhibitors

Design, synthesis, molecular docking study, and biological evaluation of salicylaldimine derivatives as potential histone deacetylases inhibitors (HDACi) and anticancer agents

Identification of Novel 4-Oxo-4H-chromen-Hydroxamic Acid Derivative Targeting Selected HDAC Isoforms